Cargando…
SNAIL vs vitamin D receptor expression in colon cancer: therapeutics implications
Vitamin D analogues with reduced hypercalcemic activity are under clinical investigation for use against colon cancer and other neoplasias. However, only a subset of patients responds to this therapy, most probably due to loss of vitamin D receptor (VDR) expression during tumour progression. Recent...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361934/ https://www.ncbi.nlm.nih.gov/pubmed/15770204 http://dx.doi.org/10.1038/sj.bjc.6602484 |